Cardlytics, Inc. (NASDAQ:CDLX) Receives Average Rating of “Hold” from Analysts

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) has received a consensus recommendation of “Hold” from the seven analysts that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a strong buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $5.20.

A number of brokerages have commented on CDLX. Evercore ISI reduced their price objective on Cardlytics from $4.00 to $3.00 and set an “in-line” rating for the company in a research report on Thursday, March 13th. Lake Street Capital decreased their price target on shares of Cardlytics from $3.00 to $2.50 and set a “hold” rating on the stock in a research note on Thursday. Finally, Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a research note on Thursday, March 13th.

Get Our Latest Stock Analysis on Cardlytics

Cardlytics Stock Up 1.8 %

Shares of CDLX opened at $1.94 on Friday. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18. The company has a 50-day simple moving average of $1.81 and a 200-day simple moving average of $2.97. Cardlytics has a 52 week low of $1.22 and a 52 week high of $10.01. The firm has a market capitalization of $100.96 million, a P/E ratio of -0.32 and a beta of 1.30.

Insider Buying and Selling at Cardlytics

In related news, CEO Amit Gupta sold 46,857 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $159,313.80. Following the sale, the chief executive officer now directly owns 418,637 shares in the company, valued at $1,423,365.80. This represents a 10.07 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Alexis Desieno sold 24,778 shares of Cardlytics stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $84,245.20. Following the completion of the transaction, the chief financial officer now owns 140,948 shares of the company’s stock, valued at approximately $479,223.20. The trade was a 14.95 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 71,938 shares of company stock valued at $244,017. 4.40% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Cardlytics

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CDLX. Deutsche Bank AG lifted its position in shares of Cardlytics by 123.8% during the first quarter. Deutsche Bank AG now owns 48,728 shares of the company’s stock worth $89,000 after purchasing an additional 26,958 shares in the last quarter. LPL Financial LLC boosted its position in Cardlytics by 30.3% in the 1st quarter. LPL Financial LLC now owns 859,406 shares of the company’s stock valued at $1,564,000 after buying an additional 200,087 shares during the last quarter. Brooktree Capital Management increased its stake in shares of Cardlytics by 27.6% in the 1st quarter. Brooktree Capital Management now owns 223,625 shares of the company’s stock valued at $407,000 after buying an additional 48,415 shares during the period. Lane Generational LLC bought a new stake in shares of Cardlytics during the first quarter worth $1,109,000. Finally, Two Sigma Advisers LP lifted its stake in shares of Cardlytics by 44.1% during the fourth quarter. Two Sigma Advisers LP now owns 36,900 shares of the company’s stock valued at $137,000 after acquiring an additional 11,300 shares during the period. Institutional investors and hedge funds own 68.10% of the company’s stock.

About Cardlytics

(Get Free Report

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Recommended Stories

Analyst Recommendations for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.